Next Generation Sequencing (NGS)

Next Generation Sequencing

Clin-Path Associates, PLC is dedicated to providing advanced molecular diagnostic services through Next Generation Sequencing (NGS) technologies to support precision medicine and targeted therapeutic decision-making. Our Molecular Pathology division works closely with oncologists, surgeons, specialists and healthcare providers to deliver accurate, clinically actionable genomic insights for the detection, characterization and management of disease. Utilizing state-of-the-art molecular platforms and comprehensive genomic profiling, Clin-Path provides rapid, high-quality testing services designed to assist clinicians in selecting personalized treatment strategies and improving patient outcomes.

Our record of excellence in delivering high-quality molecular diagnostic services is directly related to:

- Advanced Next Generation Sequencing technologies for comprehensive genomic profiling
- Accurate, clinically actionable molecular results to support targeted therapies and precision medicine
- Access to ancillary molecular testing and specialized diagnostic services including IHC, FISH and PCR methodologies
- Experienced pathology and molecular diagnostics teams dedicated to diagnostic accuracy and clinical collaboration
- Responsive local support with dependable turnaround times and direct access to pathology consultation
- Commitment to innovation, advanced diagnostics and personalized patient care